Biomarkers and mechanisms of drug-induced vascular injury in non-rodents. - Wikidata - awgldk - TriplyDB

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

http://www.wikidata.org/entity/Q36409440

about

Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse Scaffold-free, Human Mesenchymal Stem Cell-Based Tissue Engineered Blood Vessels Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?In vivo imaging of rat coronary arteries using bi-plane digital subtraction angiography Successful drug development despite adverse preclinical findings part 2: examples.Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury.Drug safety testing paradigm, current progress and future challenges: an overview.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.Vascular Imaging of Matrix Metalloproteinase Activity as an Informative Preclinical Biomarker of Drug-induced Vascular Injury.A bilayer small diameter in vitro vascular model for evaluation of drug induced vascular injury High-throughput identification of small molecules that affect human embryonic vascular development.Coronary and systemic arterial physiology and immunohistochemical markers related to early coronary arterial lesions in beagle dogs given the potassium channel opener, ZD6169, or the endothelin receptor antagonist, ZD1611.Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

P2860

Q28079801-0D2A80CF-65D6-44BE-83B7-BCC5315DFE24 Q30667582-231E60EF-F580-4781-BFC8-C48A68A9F9A3 Q34466077-F5F52042-6F21-4047-BFF3-C7E58C82FDD7 Q35036150-A17FED8C-C51F-45DD-9934-E81D3DD794E2 Q35434857-31591771-6865-44CD-9376-A20BF1D3A005 Q35603965-01A182D9-BD13-4303-8533-64F043B6EB3F Q37780630-92E66DC7-36E7-430E-98C2-0323ECFFE00F Q38207946-BCE76152-A43D-40FF-A712-8440AAC434E4 Q38365365-727A3982-4B5B-4571-A571-E7C5BE8DDAAA Q38365744-82EC4DD2-9DF0-43AE-BF4D-86B4924491AD Q38613810-C1CD0678-35FD-4103-9DD6-7E10DC46DBC6 Q42178673-BFB05C55-F6A4-42B9-8CB9-7357C29D1A52 Q42291317-4ADCFB67-7D98-42AE-8488-5E3145C31EC0 Q45169346-968D783D-9E49-4D20-BD7D-2ABB11A9BD31 Q46837495-6BCB16EC-1072-4D65-8DB3-6FB52C0704A1

P2860

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

http://www.wikidata.org/entity/Q36409440

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

@ast

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

@en

type

label

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

@ast

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

@en

prefLabel

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

@ast

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

@en

P1433

Q36409440-FD7581EB-BAD3-445A-9AB6-2551B5F89C41

P1476

Q36409440-63484529-6B1B-4B59-B738-792281975E8A

P2093

Q36409440-283671F1-9DEE-4C9F-A800-37382468D4E8

Q36409440-6B1231B1-4505-41AF-AF1D-82F79BF000CC

Q36409440-7C0AEC16-9435-4ABF-AA3D-05FC1A76541A

Q36409440-97A105A6-9113-4F25-A896-7563EAC65F50

Q36409440-A8C4C63F-70BB-483D-844E-A6114483F9FD

Q36409440-A9F92ABE-ACBF-4038-A1C6-41271D1CBADB

Q36409440-D3A94B41-D73F-49D2-A9A8-91392CD38967

Q36409440-DD5DE3E1-FDDB-4C87-B1B9-AA498B72007D

Q36409440-E5973B77-DEEF-42D8-9565-08DF8F17748D

P2860

Q36409440-02433D6B-82E5-4F40-83F3-7B2016D636F6

Q36409440-0B78B3ED-FCAE-4F24-A7CB-26C8CCCFD981

Q36409440-1AA76C96-2ABA-4E0D-8893-E83D94C69DE5

Q36409440-280DD056-1948-4A93-865F-DC76C077C87F

Q36409440-2E567B8E-EE3D-4E65-AC93-DF0028B4BA37

Q36409440-3134CAAD-DBA4-4AF5-8AEA-FBA2E0844A83

Q36409440-321F1759-7A03-46BF-8F10-ACBEFDADA585

Q36409440-3595A671-DD2B-4FB1-B9F7-39CC4CB93C64

Q36409440-367818F1-4094-4823-AB88-550007CE9A3B

Q36409440-38C7C495-D0A5-4BE7-903C-B5BDD09AE136

P304

Q36409440-F41B92FD-E90A-42E0-B4C2-88DAFF755C81

P31

Q36409440-A92B2E48-8419-41A3-9C64-68681407710C

P356

Q36409440-53F1A576-A908-4ECC-85FF-5A91F16F0D79

P407

Q36409440-C3DCF79D-DF0A-455B-AE70-2EA08B99C26E

P433

Q36409440-1B0AE8DB-8C51-4C21-9462-33BA60F6175B

P478

Q36409440-55A5AC02-5CB2-472B-9B30-15BD7D7E35D9

P577

Q36409440-BAA69831-7DF8-4484-A4EB-A5E3880FCD88

P5875

Q36409440-52B63E87-86EF-4A16-967F-3F1994C3CF7E

P698

Q36409440-48D54B64-CC48-48A0-B6A5-2C109EDBAE88

P921

Q36409440-B6A3B048-C11C-423D-B909-BAEAD91F6E09

P356

01926230500512076

P1433

Toxicologic Pathology

P1476

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.

@en

P2093

Anne Katein

http://www.w3.org/2001/XMLSchema#string

Calvert Louden

http://www.w3.org/2001/XMLSchema#string

David Brott

http://www.w3.org/2001/XMLSchema#string

Graham Betton

http://www.w3.org/2001/XMLSchema#string

Huw Jones

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Valetin

http://www.w3.org/2001/XMLSchema#string

Rudy J Richardson

http://www.w3.org/2001/XMLSchema#string

Sarah Gould

http://www.w3.org/2001/XMLSchema#string

Thomas Kelly

http://www.w3.org/2001/XMLSchema#string

P2860

Extracellular superoxide dismutase in biology and medicine

Regulated interaction of endothelin B receptor with caveolin-1

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors

Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice

Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo

The caveolae membrane system

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

Caveolin, a protein component of caveolae membrane coats

Evaluation of plasma von Willebrand factor as a biomarker for acute arterial damage in rats.

P304

19-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/01926230500512076

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7269360

http://www.w3.org/2001/XMLSchema#string

P698

16507540

http://www.w3.org/2001/XMLSchema#string

P921